NucleoBio is a leading brand committed to improving men's health through innovative prostate screening solutions. Our goal is to fill the gaps and reduce the inaccuracies of Prostate Specific Antigen (PSA) and PSA-based tests, giving men of all ages access to accurate and less stressful testing methods. By offering a groundbreaking urine-based test called Prostac, we eliminate the need for painful biopsies and reduce the anxiety associated with watchful waiting.

Our state-of-the-art test accurately detects the difference between benign and aggressive prostate cancer, providing complete peace of mind and the ideal treatment when needed. Not only does Prostac save lives by preventing misdiagnoses and overtreatment, but it also saves costs by avoiding unnecessary treatments, surgeries, and therapies. Hospitals spend an astounding $60,000 per patient on unnecessary treatment, which can lead to complications and stress.

At NucleoBio, we are dedicated to conducting medical and scientific research, particularly in the field of cancer and men's health. With our groundbreaking science and unparalleled expertise, we strive to break through the boundaries of men's health and set the gold standard for prostate disease testing. Discover the future of prostate screening with NucleoBio.

Contact us today to learn more about our organization and revolutionary technologies